Suppliers / Delpharm Huningue Sas

Delpharm Huningue Sas

France 165 employees Updated 9 July 2026

Delpharm Huningue Sas is a finished-dose manufacturer based in France. It appears in 35 regulatory filings across 6 regulators, without an active US DMF or CEP on file. Its filings concentrate with DIGEMAPS (DO), MINSA (CR) and ARCSA (EC). Its GMP standing is certified by ANSM (FR), EAEU_EEC and ANVISA (Brazil), among 8 authorities. Its most recent recorded inspection, by US FDA, closed on 30 November 2023 as VAI.

0
active US DMFs
0
valid CEPs
7
registered plants 1 with an FDA FEI number
35
filings across 6 regulators
These figures were checked against the regulators' own files on 25 July 2026
Plants
1 of 1 confirmed
Inspections
6 of 6 confirmed
EU GMP
1 of 1 confirmed
Sources: FDA Establishment Registration, read 4 May 2026. FDA drug inspection classifications, read 4 May 2026. EudraGMDP (MIA + third-country GMP certs), read 4 May 2026.

Inspection history

  • 30 November 2023 VAI US FDA
  • 8 August 2019 VAI US FDA
  • 22 June 2018 NAI US FDA
  • 23 September 2016 NAI US FDA
  • 19 December 2014 NAI US FDA
  • 15 December 2011 VAI US FDA

NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.

Registered plants

Site FDA FEI
Huninge, United Arab Emirates Not on file
Huningue, United Arab Emirates Not on file
HUNINGUE, France Not on file
France, France 3003157245
Huningue, France Not on file
Huningue, France Not on file

1 further sites are on record.

Filings and GMP by regulator

Regulator Filings GMP certificates
DIGEMAPS (DO) 11 None
MINSA (CR) 9 None
ARCSA (EC) 5 None
INVIMA (CO) 5 None
NAFDAC (NG) 4 1
NCELS (KZ) 1 1
ANSM (FR) None 8
EAEU_EEC None 3
ANVISA (Brazil) None 3
EMA None 2
MFDS (Korea) None 2
US FDA None 1

Scale

Year Revenue Exports Destinations
2024 $58.2M Not reported Not reported

Export figures are customs aggregates. We do not publish the identity of any buyer. Revenue shown in US dollars, converted from the reported currency.

Comparing suppliers?

Choose your molecules and target markets. Delpharm Huningue Sas comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Open risk flags

  • The most recent inspection outcome was VAI, on 30 November 2023.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability
EudraGMDP and national regulators
GMP certificates
Company filings
Revenue as reported